Quality of life assessment in patients receiving adjuvant therapy for breast cancer: the IBCSG approach. The International Breast Cancer Study Group.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Annals of Oncology

• Publication date

  1998-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1023/A:1008269715091PMID 9358933
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Quality of life assessment in International Breast Cancer Study Group (IBCSG) trials: practical issues and factors associated with missing data.

  1998cited by this paper
• Factors affecting baseline quality of life in two international adjuvant breast cancer trials. International Breast Cancer Study Group (IBCSG).

  1998cited by this paper
• Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument.

  1997cited by this paper
• Images in clinical medicine. Nail changes after chemotherapy.

  1997cited by this paper
• Quality of life in oncology practice: prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy.

  1997cited by this paper
• The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study.

  1996cited by this paper
• Impact of adjuvant therapy on quality of life in women with node-positive operable breast cancer. International Breast Cancer Study Group.

  1996cited by this paper
• Responsiveness of a single-item indicator versus a multi-item scale: assessment of emotional well-being in an international adjuvant breast cancer trial.

  1996cited by this paper
• Pain and depression in patients with newly diagnosed pancreas cancer.

  1995cited by this paper
• Mitozantrone‐induced onycholysis. A series of five cases

  1995cited by this paper
• The quality of quality-of-life measurements.

  1995cited by this paper
• Social support and survival among women with breast cancer

  1995cited by this paper
• The quality of quality-of-life measurements.

  1995cited by this paper
• Timing of baseline quality of life assessment in an international adjuvant breast cancer trial: its effect on patient self-estimation. The International Breast Cancer Study Group.

  1994cited by this paper
• What Do Global Self‐Rated Health Items Measure?

  1994cited by this paper
• Cancer by another name: a randomized trial of the effects of euphemism and uncertainty in communicating with cancer patients.

  1993cited by this paper
• Coping and survival in early breast cancer: an update.

  1993cited by this paper
• The Perceived Adjustment to Chronic Illness Scale (PACIS): a global indicator of coping for operable breast cancer patients in clinical trials

  1993cited by this paper
• Combination or mild single agent chemotherapy for advanced breast cancer? CMF vs epirubicin measuring quality of life.

  1993cited by this paper
• The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.

  1993cited by this paper
• The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.

  1993cited by this paper
• Prognostic value of quality of life scores in a trial of chemotherapy with or without interferon in patients with metastatic malignant melanoma.

  1993cited by this paper
• Quality of life assessment in medicine

  1992cited by this paper
• Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. Australian New Zealand Breast Cancer Trials Group.

  1992cited by this paper
• Quality of life measures for patients receiving adjuvant therapy for breast cancer: an international trial. The International Breast Cancer Study Group.

  1992cited by this paper
• The validity and relative precision of MOS short- and long-form health status scales and Dartmouth COOP charts. Results from the Medical Outcomes Study.

  1992cited by this paper
• On the receiving end. IV: Validation of quality of life indicators.

  1991cited by this paper
• CAncer rehabilitation evaluation system–short form (CARES‐SF). A cancer specific rehabilitation and quality of life instrument

  1991cited by this paper
• Onycholysis in doxorubicin-treated patients.

  1990cited by this paper
• Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist.

  1990cited by this paper
• On the receiving end--III. Measurement of quality of life during cancer chemotherapy.

  1990cited by this paper
• Costs and benefits of adjuvant therapy in breast cancer: a quality-adjusted survival analysis.

  1989cited by this paper
• A Simple, Rapid Method for Assessing Psychological Distress in Cancer Patients

  1989cited by this paper
• Quality of life in stage II breast cancer: an instrument for clinical trials.

  1988cited by this paper
• A randomized trial of two dose levels of cyclophosphamide, methotrexate, and fluorouracil chemotherapy for patients with metastatic breast cancer.

  1988cited by this paper
• Clinical applications of visual analogue scales: a critical review

  1988cited by this paper
• Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies.

  1987cited by this paper
• Cross-cultural variation in the weighting of health statements: A comparison of English and Swedish valuations

  1987cited by this paper
• Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation.

  1984cited by this paper
• On the receiving end--II. Linear analogue self-assessment (LASA) in evaluation of aspects of the quality of life of cancer patients receiving therapy.

  1983cited by this paper
• On the receiving end--patient perception of the side-effects of cancer chemotherapy.

  1983cited by this paper
• The Hospital Anxiety and Depression Scale

  1983cited by this paper
• A comparison of subjective responses in a trial comparing endocrine with cytotoxic treatment in advanced carcinoma of the breast.

  1980cited by this paper
• Evaluation of quality of life in patients receiving treatment for advanced breast cancer.

  1976cited by this paper
• Manual for the Profile of Mood States

  1971cited by this paper

• Home-based exercise improves quality of life in breast and prostate cancer survivors: A meta-analysis

  2023influential citation
• Treatment-induced symptoms, depression and age as predictors of sexual problems in premenopausal women with early breast cancer receiving adjuvant endocrine therapy

  2020cites this paper
• Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial

  2019cites this paper
• Gesamtliteraturverzeichnis

  2018cites this paper
• Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial.

  2018cites this paper
• When do patient reported quality of life indicators become prognostic in breast cancer?

  2018cites this paper
• Assessing health-related quality of life in patients with breast cancer: a reply to Maratia et al

  2017cites this paper
• Assessing health-related quality of life in patients with breast cancer: a systematic and standardized comparison of available instruments using the EMPRO tool

  2016cites this paper
• Adjuvant Tamoxifen Plus Ovarian Function Suppression Versus Tamoxifen Alone in Premenopausal Women With Early Breast Cancer: Patient-Reported Outcomes in the Suppression of Ovarian Function Trial.

  2016cites this paper
• Effects of Home-Based Walking on Quality of Life and Fatigue Outcomes in Early Stage Breast Cancer Survivors: A 12-Week Pilot Study.

  2015cites this paper
• Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials.

  2015cites this paper
• Communication about standard treatment options and clinical trials: can we teach doctors new skills to improve patient outcomes?

  2012cites this paper
• Electronic monitoring of symptoms and syndromes associated with cancer: methods of a randomized controlled trial SAKK 95/06 E-MOSAIC

  2012cites this paper
• Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancer

  2012cites this paper
• Tamoxifen Plus Chemotherapy versus Tamoxifen Alone as Adjuvant Therapies for Node-Positive Postmenopausal Women with Early Breast Cancer

  2012cites this paper
• Frühes Mammakarzinom – Lebensqualität nach Switch von Tamoxifen auf Exemestan

  2011cites this paper
• Where is the person in symptom cluster research? : the experience of symptom clusters in patients with advanced lung cancer

  2011cites this paper
• Qualité de vie et réinsertion à long terme après un cancer du sein en France

  2011cites this paper
• Adjuvant Chemotherapy for Locoregional Recurrent Breast Cancer

  2011cites this paper
• Psychologische und biologische Marker von Stress und autonomer Imbalance als Risikofaktoren für kardiovaskuläre und andere chronische Erkrankungen

  2011cites this paper
• Alternative analytical methods for the identification of cancer-related symptom clusters

  2010cites this paper
• Quality-of-Life Considerations in the Treatment of Early-Stage Breast Cancer in the Elderly

  2010cites this paper
• Health related quality of life in NCI-sponsored cancer treatment trials.

  2010cites this paper
• Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trial.

  2010cites this paper
• Changes in health-related quality of life may predict recurrent breast cancer.

  2009cites this paper
• Religiosity and quality of life in breast cancer patients.

  2009cites this paper
• Is a change in patient-reported dysphagia after induction chemotherapy in locally advanced esophageal cancer a predictive factor for pathological response to neoadjuvant chemoradiation?

  2009cites this paper
• Multivariate methods to identify cancer-related symptom clusters.

  2009cites this paper
• A randomized clinical trial of adjuvant chemotherapy for radically resected locoregional relapse of breast cancer: IBCSG 27-02, BIG 1-02, and NSABP B-37.

  2008cites this paper
• Screening for mental disorders in laryngeal cancer patients: a comparison of 6 methods

  2008cites this paper
• Health-related quality of life in breast cancer patients: A bibliographic review of the literature from 1974 to 2007

  2008cites this paper
• Adjuvant chemotherapy followed by goserelin compared with either modality alone: the impact on amenorrhea, hot flashes, and quality of life in premenopausal patients--the International Breast Cancer Study Group Trial VIII.

  2007cites this paper
• Coping with recurrent breast cancer: predictors of distressing symptoms and health-related quality of life.

  2007cites this paper
• Endocrine symptom assessment in women with breast cancer: what a simple “yes” means

  2007cites this paper
• Endocrine symptom assessment in women with breast cancer: what a simple "yes" means.

  2007cites this paper
• Quality of life and adjuvant systemic therapy for early-stage breast cancer

  2007cites this paper
• Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer

  2007cites this paper
• Use of patient-reported outcomes in phase III cancer treatment trials: lessons learned and future directions.

  2007cites this paper
• Breast: Physiologic considerations in normal, benign, and neoplastic states

  2006cites this paper
• Many quality measurements, but few quality measures assessing the quality of breast cancer care in women: A systematic review

  2006cites this paper
• Fatigue and menopausal symptoms in women with breast cancer undergoing hormonal cancer treatment.

  2006cites this paper
• Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93.

  2006cites this paper
• Original Quality of life as subjective experience: Refraining of perception in patients with colon cancer undergoing radical resection with or without adjuvant chemotherapy

  2005cites this paper
• Data from a study of effectiveness suggested potential prognostic factors related to the patterns of shoulder pain.

  2005cites this paper
• Measuring the Quality of Breast Cancer Care in Women: Summary

  2004cites this paper
• A randomized trial comparing axillary clearance versus no axillary clearance in older patients (≥ 60 years) with breast cancer: First results of International Breast Cancer Study Group Trial 10-93.

  2004cites this paper
• Toremifene and tamoxifen are equally effective for early-stage breast cancer: first results of International Breast Cancer Study Group Trials 12-93 and 14-93.

  2004cites this paper
• Outcomes Assessment in Cancer: Quality of life in breast cancer: what have we learned and where do we go from here?

  2004cites this paper
• Quantifying trade-offs: quality of life and quality-adjusted survival in a randomised trial of chemotherapy in postmenopausal patients with lymph node-negative breast cancer

  2004cites this paper
• Are health states 'timeless'? A case study of an acute condition: post-chemotherapy nausea and vomiting.

  2003cites this paper
• The efficacy of behavioral interventions for cancer treatment-related side effects.

  2003cites this paper
• Quality of life of breast cancer patients receiving high-dose-intensity chemotherapy: impact of length of cycles

  2002cites this paper
• Endocrine responsiveness and tailoring adjuvant therapy for postmenopausal lymph node-negative breast cancer: a randomized trial.

  2002cites this paper
• Randomized controlled trial of ovarian function suppression plus tamoxifen versus the same endocrine therapy plus chemotherapy: is chemotherapy necessary for premenopausal women with node-positive, endocrine-responsive breast cancer? First results of International Breast Cancer Study Group Trial 11–

  2001cites this paper
• Behavioral intervention for cancer treatment side effects.

  2001cites this paper
• REVIEW Behavioral Intervention for Cancer Treatment Side Effects

  2001cites this paper
• Effects of Inpatient Rehabilitation on Health-Related Quality of Life in Breast Cancer Patients

  2001cites this paper
• Quality of life scores predict outcome in metastatic but not in early breast cancer

  2001cites this paper
• Psychosocial predictors of outcome IV: patients with early-stage breast cancer

  2001cites this paper
• Clinical relevance of single item quality of life indicators in cancer clinical trials

  2001cites this paper
• Body experience and mental representation of body image in patients with haematological malignancies and cancer as assessed with the Body Grid.

  2001cites this paper
• Quality-of-life scores predict outcome in metastatic but not early breast cancer. International Breast Cancer Study Group.

  2000cites this paper
• Patient participation in medical decision-making: a French study in adjuvant radio-chemotherapy for early breast cancer.

  2000cites this paper
• Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VII.

  2000cites this paper
• Psychosocial predictors of outcome: time to relapse and survival in patients with early stage melanoma

  2000cites this paper
• High-dose sequential chemotherapy with recombinant granulocyte colony-stimulating factor and repeated stem-cell support for inflammatory breast cancer patients: does impact on quality of life jeopardize feasibility and acceptability of treatment?

  2000cites this paper
• Lebensqualität bei Mammakarzinom-Patientinnen

  2000cites this paper
• Patterns over time in quality of life, coping and psychological adjustment in late stage melanoma patients: An application of multilevel models

  2000cites this paper
• Long-term quality of life in premenopausal women with node-negative localized breast cancer treated with or without adjuvant chemotherapy

  2000cites this paper
• Coping with metastatic melanoma: the last year of life

  2000cites this paper
• Experiences in the realisation of a research project on anthroposophical medicine in patients with advanced cancer.

  2000cites this paper
• [Does a psychosocial group intervention program alter the quality of life of cancer patients?].

  2000cites this paper
• Defining clinical benefit in postmenopausal patients with breast cancer under second-line endocrine treatment: does quality of life matter?

  1999cites this paper
• Adjuvant systemic therapy for primary breast cancer.

  1999cites this paper
• Quality of life as subjective experience: reframing of perception in patients with colon cancer undergoing radical resection with or without adjuvant chemotherapy. Swiss Group for Clinical Cancer Research (SAKK)

  1999cites this paper
• Quality of life in postmenopausal patients with breast cancer after failure of tamoxifen: formestane versus megestrol acetate as second-line hormonal treatment. Swiss Group for Clinical Cancer Research (SAKK).

  1999cites this paper
• Quality of life assessment in the International Breast Cancer Study Group: past, present, and future.

  1998cites this paper
• S37 Quality of life assessment in the adjuvant setting: Is it relevant?

  1998cites this paper
• International Breast Cancer Study Group trials.

  1998cites this paper
• Quality of life assessment in the adjuvant setting: is it relevant? International Breast Cancer Study Group.

  1998cites this paper